The doi above is for this specific version of this dataset, which is currently the latest. Newer versions may be published in the future. For a link that will always point to the latest version, please use
doi: 10.4121/dd66122a-77c2-4f05-a34a-6b5aed8223e0

Van der Meeren, M.; Boers, Tim; de Graaf, P.; Duvivier, K.; Dreijerink, K. et. al. (2024): Data underlying the publication: Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a learning curve and predictors of success. Version 1. 4TU.ResearchData. dataset. https://doi.org/10.4121/dd66122a-77c2-4f05-a34a-6b5aed8223e0.v1

Dataset

• Clinical Health (organs, Diseases and Abnormal Conditions)
• Health

retrospective study, RFA, table, Thyroid nodule

CC BY-NC 4.0

RefWorks, BibTeX, Reference Manager, Endnote, DataCite, NLM, DC, CFF

by M. Van der Meeren , Tim Boers , P. de Graaf , K. Duvivier , K. Dreijerink , L. Deden , P. Veendrick , P. Cernohorsky , F. Joosten , B. Savelberg , S. Braak , S. Roerink , Michel Versluis , S. Manohar , W. Oyen

Context Radiofrequency ablation (RFA) is used as treatment for symptomatic thyroid nodules. However, factors influencing the volume reduction ratio (VRR) at 12 months are not yet fully understood. Objective The primary objective was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months. Design This is a retrospective Dutch multi-center study. Patients and intervention Patients who underwent RFA for symptomatic thyroid nodules with available ultrasound follow-up were eligible for this study. Main outcome measures Ultrasound based VRR at 12 months and chronologically numbered RFA procedures. All patients’ baseline, ultrasound, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months. 

• 2024-09-30 first online, published, posted

4TU.ResearchData

table/word document

1. Rijnstate, Dept. of Radiology and Nuclear Medicine, Arnhem, The Netherlands
2. Rijnstate, Dept. of Internal Medicine, Arnhem, The Netherlands
3. University of Twente, Multi-modality Medical Imaging, TechMed Center, Enschede, The Netherlands
4. Amsterdam UMC, Location Vrije Universiteit Amsterdam, Dept. of Radiology and Nuclear Medicine, Amsterdam,
The Netherlands
5. Amsterdam UMC, Location Vrije Universiteit Amsterdam, Dept. of Endocrinology and Metabolism, Amsterdam,
The Netherlands.
6. Meander Medical Center, Dept. of Internal Medicine, Amersfoort, The Netherlands
7. Ziekenhuisgroep Twente, Dept. of Radiology, Almelo, The Netherlands
8. University of Twente, Physics of Fluids, TechMed Center, Enschede, The Netherlands
9. Humanitas University and Clinical Research Center, Milan, Italy
10. Radboudumc, Dept. of Radiology and Nuclear Medicine, Nijmegen, The Netherlands